Pajson Agro IPO Monitoring Agency Report Flags GCP Cap Breach and Capex Delay for Q4 FY26
Pajson Agro India Limited filed its IPO proceeds utilisation statement and CARE Ratings' Monitoring Agency Report for the quarter ended March 31, 2026, revealing a ₹1.96 crore reallocation from issue expenses to GCP, raising GCP to ₹10.43 crore — above the ₹10 crore regulatory cap. Capital expenditure for the Vizianagaram cashew processing facility saw only ₹6.78 crore deployed against a planned ₹20.00 crore, with ₹50.22 crore of the unutilised ₹50.31 crore parked in a Fixed Deposit with Kotak Mahindra Bank at 6.60% return.

*this image is generated using AI for illustrative purposes only.
Pajson Agro India Limited has filed a statement of deviation or variation in the utilisation of proceeds raised through its Initial Public Offering (IPO), pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Alongside this, CARE Ratings Limited, the appointed Monitoring Agency (MA), has submitted its Monitoring Agency Report for the quarter ended March 31, 2026. The filing was submitted to BSE Limited on May 07, 2026, by Compliance Officer and Company Secretary Roopal Saxena.
IPO and Issuer Details
The company raised funds through a Public Issue-SME IPO, with allotment completed on December 16, 2025. The key parameters of the fund raise and issuer profile are summarised below:
| Parameter: | Details |
|---|---|
| Mode of Fund Raising: | Public Issue-SME IPO |
| Issue Period: | December 11, 2025 to December 15, 2025 |
| Date of Allotment: | December 16, 2025 |
| Amount Raised: | ₹74.45 crore (63,09,600 equity shares at ₹118 per share, including share premium of ₹108 per equity share) |
| Promoters: | Aayush Jain, Anjali Jain and Pulkit Jain |
| Industry/Sector: | Fast Moving Consumer Goods (FMCG) |
| Report Filed For: | Quarter ended March 31, 2026 |
| Monitoring Agency: | CARE Ratings Limited |
Deviation in Use of IPO Proceeds
A deviation was identified in the utilisation of IPO proceeds. The Board reduced the allocation towards issue expenses by ₹1.96 crore, correspondingly increasing the allocation to General Corporate Purposes (GCP). This change was approved by shareholders on August 26, 2025. The Audit Committee reviewed and noted that the issue expenses of ₹8.98 crore mentioned in the offer document were on an approximate basis, and the actual expense incurred was ₹7.02 crore. The remaining ₹1.96 crore was accordingly moved towards GCP, authorised by the Board vide resolution dated December 26, 2025.
However, CARE Ratings flagged that the revised GCP allocation of ₹10.43 crore exceeds the stipulated cap of ₹10 crore (being the lower of 15% of amount raised or ₹10 crore, as per the offer document), and no corresponding approval for such excess has been shared with CARE Ratings Limited. No comments were received from the auditors on this matter.
Fund Utilisation Breakdown
The following table details the original and revised cost allocations, along with quarterly utilisation progress:
| Object: | Original Cost (₹ Crore) | Revised Cost (₹ Crore) | Utilised at Beginning of Quarter (₹ Crore) | Utilised During Quarter (₹ Crore) | Utilised at End of Quarter (₹ Crore) | Total Unutilised (₹ Crore) |
|---|---|---|---|---|---|---|
| Capital Expenditure – Vizianagaram Cashew Processing Facility: | 57.00 | 57.00 | 0.00 | 6.78 | 6.78 | 50.22 |
| General Corporate Purposes: | 8.47 | 10.43 | 10.34 | 0.00 | 10.34 | 0.09 |
| Issue Expenses: | 8.98 | 7.02 | 7.02 | 0.00 | 7.02 | 0.00 |
| Total: | 74.45 | 74.45 | 17.36 | 6.78 | 24.14 | 50.31 |
As reflected above, ₹6.78 crore was utilised during the quarter towards civil construction work and purchase of plant and machinery for the Vizianagaram facility, leaving ₹50.22 crore unutilised under this head. The GCP allocation of ₹10.43 crore saw ₹10.34 crore utilised, with ₹0.09 crore remaining. Issue expenses of ₹7.02 crore were fully deployed. The CA certificate was issued by P.K. Maheshwari and Co (Statutory Auditor) dated April 29, 2026.
Deployment of Unutilised Proceeds
The total unutilised amount of ₹50.31 crore has been deployed as follows:
| Sr. No.: | Instrument / Entity: | Amount Invested (₹ Crore) | Maturity Date: | Earning (₹ Crore) | Return on Investment (%): | Market Value at End of Quarter (₹ Crore) |
|---|---|---|---|---|---|---|
| 1. | Fixed Deposit – Kotak Mahindra Bank (A/c 8350877747) | 50.22 | December 24, 2026 | 0.78 | 6.60% | 51.00 |
| 2. | Kotak Mahindra Bank – Monitoring Account | 0.09 | – | – | – | – |
| Total: | 50.31 |
Implementation Delay at Vizianagaram Facility
The Monitoring Agency report noted a delay in the implementation of the capital expenditure object. Against a planned deployment of ₹20.00 crore for the relevant financial year, only ₹6.78 crore was utilised, resulting in a shortfall of ₹13.22 crore. The company attributed the delay to the following factors:
- The company was listed on December 18, 2025, and during the fourth quarter, purchase orders aggregating to ₹27.52 crore were issued, with payments contractually linked to the achievement of specified milestones.
- The month of January in Andhra Pradesh is marked by major festive occasions, resulting in an acute shortage of labour, causing land levelling activities to commence only in February 2026.
- Delayed commencement of work meant that relevant milestones could not be achieved within stipulated timelines, leading to corresponding payment delays.
The Board stated that discussions were held with concerned vendors and a mutual understanding has been reached, with the company confident that project timelines shall be aligned with the planned schedule going forward. Disbursement of funds and release of payments shall be undertaken strictly in accordance with the achievement of agreed milestones and/or the delivery schedule of the machinery.
Regarding regulatory approvals, preconstruction approvals for the Vizianagaram facility are in place. In addition to the Consent to Establish (CTE) obtained earlier, the company has also secured permission from the Irrigation Department vide letter dated March 9, 2026. The company is presently in the process of obtaining requisite approvals from the Visakhapatnam Metropolitan Region Development Authority (VMRDA), following which all other necessary statutory and regulatory approvals will be obtained in due course.
Regulatory Context
The deviation or variation, as defined under applicable regulations, may refer to:
- Deviation in the objects or purpose for which the funds have been raised
- Deviation in the amount of funds utilised as against what was originally disclosed
- Change in terms of a contract referred to in the fund-raising document, such as a prospectus or letter of offer
The statement was duly reviewed by the Audit Committee and filed in accordance with the requirements of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Monitoring Agency Report was prepared by CARE Ratings Limited and signed by Associate Director Rajan Sukhija.
Historical Stock Returns for Pajson Agro
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.84% | +5.15% | -7.47% | +51.31% | +51.31% | +51.31% |
Will Pajson Agro India Limited seek formal shareholder or regulatory approval to legitimize the excess GCP allocation of ₹10.43 crore that breaches SEBI's stipulated ₹10 crore cap, and what penalties could SEBI impose if it fails to do so?
Given that only ₹6.78 crore of the planned ₹20 crore capex was deployed in Q4 FY2026, how will the significant shortfall of ₹13.22 crore impact the projected commissioning timeline of the Vizianagaram cashew processing facility and the company's revenue outlook?
With ₹50.22 crore of IPO proceeds parked in a fixed deposit maturing in December 2026, what is the company's revised capex deployment schedule, and could further delays trigger additional regulatory scrutiny or investor concerns?































